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Directional cell movement in response to external 
chemical gradients requires establishment of front–rear 
asymmetry, which distinguishes an up-gradient protrusive 
leading edge, where Rac-induced F-actin polymerization 
takes place, and a down-gradient retractile tail (uropod in 
leukocytes), where RhoA-mediated actomyosin 
contraction occurs. The signals that govern this spatial 
and functional asymmetry are not entirely understood. We 
show that the human type I phosphatidylinositol 4-
phosphate 5-kinase isoform β (PIPKIβ) has a role in 
organizing signaling at the cell rear. We found that PIPKIβ polarized at the uropod of 
neutrophil-differentiated HL60 cells. PIPKIβ localization was independent of its lipid kinase 
activity, but required the 83 C-terminal amino acids, which are not homologous to other 
PIPKI isoforms. The PIPKIβ C terminus interacted with EBP50 (4.1-ezrin-radixin-moesin 
(ERM)-binding phosphoprotein 50), which enabled further interactions with ERM proteins 
and the Rho-GDP dissociation inhibitor (RhoGDI). Knockdown of PIPKIβ with siRNA 
inhibited cell polarization and impaired cell directionality during dHL60 chemotaxis, 
suggesting a role for PIPKIβ in these processes.  
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Abbreviations used in this paper: dHL60, DMSO-differentiated HL60; ERM, ezrin/radixin/moesin; EBP50, 4.1-
ERM-binding phosphoprotein 50; FERM, band 4.1 protein-ezrin-radixin-moesin; fMLP, N-formyl-methionyl-
leucyl-phenylalanine; KHD, kinase homology domain; MLC, myosin light chains; PBD, p21-binding domain; p-
ERM, phosphorylated-ERM; PH, pleckstrin homology domain; PI3K, phosphatidylinositol 3-kinase; PI(4,5)P2,
 
phosphatidylinositol-4,5-bisphosphate; PIP3, phosphatidylinositol
 3,4,5-triphosphate; PIPKI, type I 
phosphatidylinositol 4-phosphate 5-kinase; PTX, pertussis toxin; RhoGDI, Rho-GDP dissociation inhibitor; 
ROCK, p160-Rho-associated coil-containing protein kinase. 
 
  
Many immune system cells detect the direction and intensity of an 
extracellular chemical gradient, and migrate toward the source of 
stimulus. This process, called chemotaxis, is essential for immune system 
function and homeostasis, and its deregulation is associated with chronic 
inflammation. Migrating cells are morphologically and functionally 
asymmetric, with two opposite compartments: the leading edge at the front and the uropod at the 
rear. Establishing and maintaining cell polarity in response to extracellular stimuli appear to be 
mediated by feedback loops involving phosphatidylinositol 3-kinases (PI3Ks), the Rho family of 
small GTPases, integrins, microtubules, and vesicular transport (Ridley et al., 2003; Charest and 
Firtel, 2006; Willard and Devreotes, 2006). These feedback loops are regulated in turn by the 
asymmetric distribution of cell membrane microdomains during migration (Gómez-Moutón et al., 
2001, 2004; Mañes and Viola, 2006; Nuzzi et al., 2007).  
Dynamic remodeling of actin cytoskeletal elements, which is controlled by the Rho family of 
GTPases, is a driving force for immune cell polarization and migration. Rac and Cdc42 GTPases are 
associated with leading edge protrusion and orientation of migration (Ridley et al., 2003; Willard and 
Devreotes, 2006); in contrast, RhoA is implicated in uropod formation (Yoshinaga-Ohara et al., 
2002; Xu et al., 2003; Lee et al., 2004). RhoA activates ROCK (p160-Rho-associated coil-containing 
protein kinase), which phosphorylates myosin light chains (MLC) and thus increases actin filament 
contraction (Alblas et al., 2001; Worthylake et al., 2001). Local ATP production by mitochondria 
regulates myosin II phosphorylation (Campello et al., 2006).  
The mechanisms by which RhoA and Rac/Cdc42 segregate to opposite poles are not well 
understood. In DMSO-differentiated HL60 cells (dHL60; a neutrophil-like cell line), mutual 
suppression of one GTPase by the other was proposed to allow Rac to predominate at the leading 
edge and RhoA at the uropod (Xu et al., 2003). Rac activation at the uropod has nonetheless been 
reported (Gardiner et al., 2002). The signaling pathways involved in Rac/Cdc42 and RhoA activation
are only partially defined. In dHL60 and Jurkat T cells, chemoattractant receptors simultaneously 
initiate two divergent signals, activating Rac/Cdc42 (via trimeric Gi proteins) at the leading edge and
RhoA (via trimeric G12/G13 proteins) at the uropod (Xu et al., 2003;
 Tan et al., 2006). Nonetheless, 
signaling pathways specifically triggered at the cell front may also activate RhoA at the uropod (Van 
Keymeulen et al., 2006; Filippi et al., 2007). In T cells, ERM proteins exercise control over RhoA 
activation and uropod formation (Lee et al., 2004), and can also be a downstream target of the 
RhoA/ROCK pathway (Yonemura et al., 2002; Yoshinaga-Ohara et al., 2002). This apparently 
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contradictory evidence suggests a requirement for additional signaling pathways to establish front–
rear cell polarity.  
The lipid phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2]
 might be a key participant in the 
integration of the front–rear signaling. At the leading edge, PI(4,5)P2 is a substrate shared
 by PI3K 
and PLC. PI(4,5)P2 phosphorylation by PI3K generates
 phosphatidylinositol 3,4,5-triphosphate 
(PIP3), a hallmark of
 the leading edge in polarized neutrophils (Ridley et al., 2003; Mañes et al., 
2005). Antagonism between PI3K and the PIP3 phosphatase PTEN (phosphatase and tensin 
homologue on chromosome 10) was proposed as a guidance system for directed migration of the 
amoeba Dictyostelium (Ridley et al., 2003), but its importance in leukocyte chemotaxis is debated 
(Lacalle et al., 2004; Nombela-Arrieta et al., 2004; Li et al., 2005; Van Keymeulen et al., 2006; 
Nishio et al., 2007). PI(4,5)P2 hydrolysis by PLC generates inositol 1,4,5-triphosphate
 and 
diacylglycerol (DAG), necessary for Ca2+ mobilization into cells and PKC activation, respectively 
(Rebecchi and Pentyala, 2000). PLC activity is needed for T cell chemotaxis via a Ca2+-
independent/DAG-dependent mechanism (Cronshaw et al., 2006). PI(4,5)P2 may also regulate
 
cofilin location at the pseudopodia of carcinoma cells, proposed as another guidance system 
(Mouneimne et al., 2006). At the uropod, PI(4,5)P2 is a major regulator of ERM protein activation
 of 
chemotaxing leukocytes (Yonemura et al., 2002; Fievet et al., 2004), and directly regulates many 
actin-binding and actin-remodeling proteins, including Rho GTPases (Caroni, 2001; Ling et al., 
2006). Given the high steady-state level of PI(4,5)P2 and the broad
 range of its potential targets, 
functional compartmentalization of PI(4,5)P2 inside the cell may be crucial during chemotaxis.
  
Although PI(4,5)P2 can be synthesized from PI(5)P (Rameh et al., 1997),
 the main biosynthetic 
pathway is regulated by the so-called type I phosphatidylinositol-phosphate kinases (PIPKIs), which 
use PI(4)P as substrate and thus function as PI(4)P-5 kinases (Ishihara et al., 1998). There are three 
PIPKI isoforms ( , β, and ); human PIPKI  is equivalent to the mouse PIPKIβ isoform and vice 
versa (to avoid confusion, we will use human nomenclature in this manuscript). There are also at 
least two PIPKI  isoforms (PIPKI 635 and PIPKI 661), generated by alternative splicing. In 
fibroblasts, the three PIPKI isoforms have distinct subcellular locations (Ling et al., 2006).  
Here, we found that the human PIPKIβ isoform localizes to the uropod of polarized dHL60 cells; this 
polarized distribution requires the PIPKIβ C-terminal domain. At the uropod, PIPKIβ may serve as a 
scaffold for interaction among several proteins including, but not limited to, EBP50, ERM, and 
RhoGDI. PIPKIβ knockdown impaired cell polarity and directionality during chemotaxis. We thus 
propose PIPKIβ as a new element involved in a positive feedback loop that regulates directional 
leukocyte motility by organizing specific signaling pathways at the cell posterior.  
 
  
Human PIPKIβ localizes to the uropod of polarized dHL60 
cells 
To study PI(4,5)P2 compartmentalization in leukocyte chemotaxis,
 we 
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used real-time videomicroscopy to analyze localization of the mouse 
orthologues for three GFP-tagged PIPKI isoforms (PIPKI , PIPKIβ, and 
PIPKI 635) in dHL60 cell chemotaxis toward the neutrophil 
chemoattractant N-formyl- methionyl-leucyl-phenylalanine (fMLP). We found that as the cells 
polarized, GFP-PIPKIβ accumulated almost exclusively at the sides and back of moving cells (Fig. 1 
A; Video 1, available at http://www.jcb.org/cgi/content/full/jcb.200705044/DC1). In contrast, GFP-
PIPKI  and GFP-PIPKI 635 homogeneously stained the cytosol and/or membrane, with no specific 
cell pole dominance during chemotaxis (Fig. 1 A; Videos 2 and 3). HA-tagged PIPKIβ also localized 
at the uropod of fMLP-stimulated dHL60 cells, indicating that uropod localization of this PIPK 
isoform was not the consequence of GFP fusion (Fig. S1 A, available at 
http://www.jcb.org/cgi/content/full/jcb.200705044/DC1). Immunofluorescence analysis of 
endogenous PIPKI isoforms in fMLP-stimulated dHL60 cells suggested PIPKIβ accumulation at the 
uropod (Fig. 1 B; Fig. S1 B). Finally, GFP-tagged PIPKIβ was confined at the uropod of Jurkat T 
cells polarized by CXCL12 stimulation, indicating that PIPKIβ localization at the cell rear is found in 
different cell types (Fig. S1 C).  
 
  
PIPKIβ is required for dHL60 cell polarity and chemotaxis 
To address the relevance of PIPKIβ in chemotaxis, we transfected dHL60 cells with mismatched or 
PIPKIβ-specific siRNA. Two different PIPKIβ-siRNAs reduced mRNA levels specifically for 
PIPKIβ, but did not affect the other PIPKI isoforms (Fig. 2 A); moreover, these PIPKIβ siRNAs 
reduced PIPKIβ protein levels (Fig. 2 B). Targeting of endogenous PIPKIβ significantly reduced 
dHL60 cell polarization, as determined by the concurrent loss of F-actin accumulation at the leading 
edge and of phosphorylated-ERM (p-ERM) at the uropod (Fig. 2 C). Moreover, PIPKIβ-specific, but 
not mismatched siRNA, reduced dHL60 chemotaxis toward fMLP in a transwell assay (Fig. 2 D). To 
further analyze the role of PIPKIβ in chemotaxis, we performed time-lapse chemotactic assays of 
control and PIPKIβ-specific siRNA-transfected dHL60 cells. PIPKIβ-specific siRNA significantly 
impaired persistence during migration (0.85 ± 0.02 vs. 0.69 ± 0.03, for control and PIPKIβ siRNA-
transfected cells, respectively; P <0.001, two-tailed t test), but did not affect cell speed (7.84 ± 0.34 
µm/min for control, 8.17 ± 0.6 µm/min for PIPKIβ-siRNA, P = 0.63, two-tailed t test; Fig. 2 E). The 
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Figure 1. Human PIPKIβ polarizes to the uropod during dHL60 cell 
chemotaxis. (A) Time-lapse Nomarski and fluorescent images of dHL60 
cells expressing GFP-tagged PIPKI , PIPKIβ, and PIPKI 635 isoforms 
migrating toward an fMLP-loaded micropipette. Time in seconds from the 
first frame (0 s). (B) Immunofluorescence analysis of endogenous PIPKI 
isoforms in uniformly stimulated dHL60 cells. Bar, 10 µm. Results are 
representative of at least 20 cells recorded in each of three independent 
experiments. 
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mean translocation rate over a 7-min period was also higher in PIPKIβ siRNA (11.26 ± 0.41 
µm/min) than in control siRNA (9.89 ± 0.49 µm/min) transfected cells (P = 0.07, two-tailed t test). 
These results suggest a role for endogenously expressed PIPKIβ in the chemoattractant-elicited 
leukocyte cell polarity program. 
 
  
Signaling pathways involved in uropod accumulation of PIPKIβ 
Chemoattractant stimulation in leukocytes appears to generate two opposing signals, mediated by 
different trimeric G proteins; pertussis toxin (PTX)-sensitive Gi proteins activate leading
 edge 
signaling pathways, and PTX-insensitive G12/G13 elicit
 the signals that shape the uropod (Xu et al., 
2003; Tan et al., 2006). PTX treatment of dHL60 cells did not prevent fMLP-induced PIPKIβ 
accumulation at the uropod (Fig. 3 A; quantification in Fig. 3 F). Overexpression of the C terminus 
of G 12 and G 13, or of the
 catalytically inactive G 12
(Q209L/D277N) and G 13
(Q226L/D294N) 
mutants, prevented PIPKIβ polarization (Fig. 3, B and C). 
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Figure 2. PIPKIβ knockdown inhibits dHL60 cell polarization and 
chemotaxis. (A) PIPKIβ knockdown in dHL60 cells 48 h after 
transfection with 50 nM control or PIPKIβ-specific siRNA, as determined 
by quantitative RT-PCR (see Materials and methods). The results are 
normalized to the relative PIPKIβ mRNA levels in cells transfected with 
control siRNA (representative of five experiments). (B) Crude lysates 
(80 µg/lane) from cells as in A were analyzed by immunoblot with anti-
PIPKIβ and anti-actin antibodies. The graph represents mean ± SEM of 
densitometry values for the PIPKIβ band from three independent 
experiments, taking the band in siRNA control cells as 100%. (C) Cell 
polarity depends on PIPKIβ. Uniformly stimulated dHL60 cells 
transfected with control or two PIPKIβ-specific siRNA were stained with 
phalloidin (red) and phospho-ERM proteins (green) as leading edge and 
uropod markers, respectively. Only cells showing clear segregation of 
phalloidin and phospho-ERM proteins were scored as polarized. Data 
are mean ± SEM of the percentage of polarized cells from three 
independent experiments. Representative fields for each condition are 
shown (left panels). Bar, 10 µm. (D) Cell chemotaxis depends on 
PIPKIβ. Chemotaxis was analyzed for Cy3-labeled control or PIPKIβ-
specific siRNA-transfected dHL60 cells in transwell assays (see 
Materials and methods). Data are mean ± SEM (expressed as 
percentage) of cells migrating toward fMLP in three independent 
experiments. (*, P < 0.01; two-tailed t-test). (E) Representative 
examples of migration tracks of control or PIPKIβ-specific siRNA-
transfected cells chemotaxing toward fMLP. In these and subsequent 
composite migration figures, randomly selected individual migration 
tracks were copied and combined into a single figure. The white dot 
represents the fMLP-loaded pipette tip; bar, 10 µm. Right panels show 
quantification of the persistence of migratory directionality and velocity 
of control or PIPKIβ siRNA-transfected cells. D/T ratios represent the 
ratio of the direct distance from start to end point [D] divided by total 
track distance [T]. Velocity was calculated as total distance divided by 
time (µm/min). Data were pooled from three independent experiments; 
error bars indicate SEM based on n = 22–25 cells (*, P < 0.001; two-
tailed t test). 
Figure 3. Signaling pathways involved in PIPKIβ 
polarization. Polarization of GFP- or RFP-tagged PIPKIβ was 
analyzed in fMLP-stimulated dHL60 cells after treatment with 
PTX (A), overexpression of dominant-negative G 12 and G 13 
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We analyzed PIPKIβ polarization in dHL60 cells expressing a dominant-negative RhoA mutant 
(RhoAN19). Although RhoAN19 overexpression altered the dHL60 cell phenotype, PIPKIβ 
concentration at the uropod persisted in a large proportion of cells (Fig. 3 D). ROCK is a major 
RhoA target, and controls actomyosin contraction by regulating the phosphorylation state of MLC 
(Kimura et al., 1996). Cell treatment with the ROCK inhibitor Y-27632 resulted in cells with 
extended uropods, probably due to the inability of the cell to retract the rear; indeed, Y-27632 
treatment greatly reduced dHL60 cell migration (unpublished data). PIPKIβ was localized diffusely 
in these long uropods, but was excluded from the leading edge (Fig. 3 E), indicating that ROCK 
inhibition did not prevent PIPKIβ polarization. These results suggest that PIPKIβ polarization is 
independent of RhoA signaling. 
The PIPKIβ C terminus acts as a uropod-targeting sequence 
We studied the molecular determinants for specific PIPKIβ recruitment to the uropod. PIPKI has a 
conserved kinase homology domain (KHD) and sequence-divergent N and C termini; we thus 
performed mutagenesis analysis that affected each of these regions (Fig. 4 A). Lipid kinase activity 
appeared not to be required for PIPKIβ-specific location, as the kinase-dead PIPKIβK138A mutant 
(Itoh et al., 2000) concentrated at the uropod of polarized cells, as did PIPKIβwt (Fig. 4, B and C; 
Fig. S1 D). Many PIPKIβK138A-expressing cells nonetheless had longer tails than PIPKIβwt-
expressing cells (Video 4, available at http://www.jcb.org/cgi/content/full/jcb.200705044/DC1). 
Consistent with this impairment in tail retraction, cell speed was reduced in PIPKIβK138A-expressing 
dHL60 cells compared with mock- or PIPKIβwt-expressing cells (7.0 ± 0.6 µm/min for PIPKIβwt vs. 
3.9 ± 0.3 µm/min for the PIPKIβK138A mutant; Fig. 4 J). PIPKIβK138A-expressing cells also showed 
a significant reduction in directionality compared with PIPKIβwt-expressing cells (Fig. 4, I and J).  
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mutants (B), overexpression of the catalytically inactive G 12
(Q209L/D277N) and G 13
(Q226L/D294N) mutants (C), dominant-
negative GFP-RhoAN19 mutant (D), or after treatment with 
ROCK inhibitor Y-27632 (E). Mock-transfected or vehicle-
treated cells were analyzed in parallel. Representative cells in 
each experimental condition are shown; bar, 10 µm. (F) 
Quantification of the effect on PIPKIβ polarization of the 
inhibitors or mutants tested. Data are mean ± SEM from three 
independent experiments; at least 30 cells were recorded in 
each experiment for each condition. 
Figure 4. Polarization of PIPKIβ to the cell uropod requires the C 
terminus. (A) Scheme of the PIPKIβ mutants and chimeras used. The 
KHD is shown in pastel colors; the activation loop (AL) is delimited by 
dashed lines. The K138A mutation is indicated by a solid line. (B–H) 
subcellular distribution of the different GFP-tagged mutants in polarized 
dHL60 cells after uniform stimulation with fMLP. Cells are representative of 
at least 20 cells recorded in three independent experiments; bar, 10 µm. (I) 
Composite collection of representative tracks for fMLP-induced migration 
of dHL60 cells expressing the indicated PIPKIβ mutants; bar, 10 µm. (J) 
Quantification of persistence of migratory directionality (D/T) and velocity 
of the transfected cells. Data (mean ± SEM) were obtained from video 
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Within the KHD, the activation loop (PIPKIβ amino acids 355–376) confers substrate specificity, 
whereas K397 and K398 are important for membrane anchoring (Arioka et al., 2004). In PIPKI , the 
KHD N-terminal portion is also required for membrane association (Arioka et al., 2004), suggesting 
that the KHD is necessary and sufficient for plasma membrane localization. Our results confirmed 
these observations, as GFP-tagged PIPKIβ 34 (Fig. 4 D) and PIPKIβ 395 (Fig. 4 E) deletion 
mutants localized to cytosol. These mutants were also homogeneously distributed in polarized cells, 
indicating that plasma membrane association is a major determinant for PIPKIβ polarization at the 
uropod. 
The PIPKIβ 456 mutant, which retains KHD but lacks the last 83 amino acids (83aa-tail), retained 
membrane association but was homogeneously distributed in fMLP-stimulated cells (Fig. 4 F). To 
further confirm the role of this 83aa-tail in uropod targeting, we produced a chimeric protein by 
fusing the 83aa-tail of PIPKIβ to a C terminus–deleted PIPKI  mutant (PIPKI 1-502). PIPKI 1–502 
stained the cell periphery evenly (Fig. 4 G; Video 5, available at 
http://www.jcb.org/cgi/content/full/jcb.200705044/DC1); introduction of the 83aa-tail from the β 
isoform into this mutant (PIPKI 1–502β455–539) was sufficient to redirect this chimera to the uropod 
(Fig. 4 H; Video 6), indicating the relevance of the PIPKIβ C terminus for uropod polarization. When 
expressed alone in dHL60 cells, the 83aa-tail localized in the perinuclear region (unpublished data), 
supporting the idea that PIPKIβ localization at the uropod requires kinase binding to the plasma 
membrane.  
We also observed dose-dependent inhibition of chemoattractant-induced cell asymmetry by PIPKIβ
456 overexpression. Time-lapse experiments indicated that PIPKIβ 456-expressing cells were 
unable to chemotax toward fMLP, showing a severe reduction in cell directionality and speed (Fig. 4, 
I and J). Introduction of the 83aa-tail in the chimera PIPKI 1–502β455–539 restored cell velocity (6.1 
± 0.5 µm/min), although directionality was reduced compared with PIPKIβwt-expressing cells (0.83 
for PIPKIβwt vs. 0.75 for PIPKI 1–502β455–539; Fig. 4 J; borderline significance). This small 
difference in directional persistence in PIPKI 1–502β455–539-expressing cells suggests nontotally 
overlapping functions for other domains of PIPKIβ and PIPKI isoforms in cell chemotaxis.  
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time-lapse microscopy of a total of 18–25 cells. Probability was calculated 
by two-tailed t-test and is indicated for the corresponding mutants. The 
mean translocation rates (± SEM), calculated as total cell migration over 
2–5-min periods (or 2–8 min for the PIPKIβK138A mutant), were 16.1 ± 
0.75, 13.57 ± 0.66, 6.11 ± 0.62, 4.47 ± 0.27, and 11.08 ± 0.57 µm/min for 
mock-, PIPKIβwt-, PIPKIβK138A-, PIPKIβ 456-, and PIPKI 1–502β455–539-
expressing cells, respectively. 
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Overexpression of the PIPKIβ 456 mutant prevents cell orientation toward a gradient
To further study the loss of polarity induced by PIPKIβ 456 overexpression, we analyzed the 
asymmetry of early fMLP-induced signals. The AKT-PH domain (AKT-PH-GFP) is recruited 
persistently at the up-gradient edge in dHL60 cells (Gómez-Moutón et al., 2004), and this pattern 
was not changed by PIPKIβwt overexpression (Fig. 5 A; Video 7, available at 
http://www.jcb.org/cgi/content/full/jcb.200705044/DC1). In PIPKIβ 456-overexpressing cells, 
AKT-PH-GFP was recruited simultaneously to pseudopods formed on the cell down- and up-
gradient sides (Fig. 5 B; Video 8). We also analyzed the dynamics of the GFP-tagged Pak-1 binding 
domain (PBD-GFP) to monitor active Rac, a pathway involved in leading edge formation. PBD-GFP 
cycled between the cytosol and the membrane exclusively at the leading edge of PIPKIβwt-
expressing cells during chemotaxis (Fig. 5 C; Video 9). In PIPKIβ 456 cells, however, PBD-GFP 
was recruited very transiently to pseudopods that formed around the cell perimeter (Fig. 5 D; Video 
10). Together, these results indicate that PIPKIβ 456 prevents morphological and functional 
polarization of chemoattractant-stimulated dHL60 cells, even though these cells express endogenous 
PIPKIβ.  
 
  
PIPKIβ 456 might induce this dominant-negative effect on cell polarity by deregulating PI(4,5)P2 
levels. PIPKIβ 456 retains intact KHD and the activation loop, and therefore this mutant might 
retain the ability to produce PI(4,5)P2. To address
 this point, we performed an in vitro kinase assay 
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Figure 5. Overexpression of PIPKIβ 456 prevents dHL60 cell 
polarity. (A–D) PI3K and Rac activation were analyzed by time-lapse 
video microscopy of RFP-PIPKIβwt- and RFP-PIPKIβ 456-expressing 
dHL60 cells, using the AKT-PH-GFP (A and B) and the PBD-GFP (C 
and D) domains as probes for PI3K and Rac, respectively. Time-lapse 
images for Nomarski and red-green channel merge are shown. In D, 
micropipette location is indicated by a black dot; arrowheads indicate 
areas of the membrane recruiting the PBD-GFP probe. The cells shown 
are representative of at least 30 recorded in three independent 
experiments. (E) Chemoattractants stimulate PIPKIβ- and PIPKIβ 456-
induced PI(4,5)P2 production. HA-tagged PIPKIβ constructs as 
indicated were immunoprecipitated from starved or CXCL12-stimulated 
HEK-293 cells; kinase activity was analyzed in an in vitro kinase assay 
using PI(4)P as substrate. The same cell extracts were analyzed by 
immunoblot to determine the expression of each PIPKIβ construct 
(bottom panel). The right panel shows densitometry values for the PI
(4,5)P2 band. One representative experiment of two is shown. (F) 
PIPKIβ 456 kinase activity is dispensable for prevention of cell polarity. 
PIPKIβ-, PIPKIβ 456-, or kinase-dead PIPKIβ 456K138A-expressing 
dHL60 cells were stimulated with fMLP and stained with phalloidin (red) 
to detect F-actin. Quantification of polarized cells, determined as 
phalloidin staining at the leading edge, is shown (right panel). (G) 
PIPKIβ overexpression restores cell polarity in PIPKIβ 456-expressing 
cells. dHL60 cells were transfected with the indicated plasmids mixtures 
(pRFP-PIPKIβ and pEGFP; pGFP-PIPKIβ 456 and pRFP; pRFP-
PIPKIβ and pGFP-PIPKIβ 456) at a 1:1 ratio. After stimulation, cells 
were stained for phospho-ERM (blue). Single-color images are provided 
as supplemental material (available at 
http://www.jcb.org/cgi/content/full/jcb.200705044/DC1). Only cells 
showing phospho-ERM staining at the uropod were scored as polarized 
(right panel). The cells shown (A–D, F, and G) are representative of at 
least 30 recorded in three independent experiments. Error bars indicate 
SEM. Bar, 10 µm. 
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using HA-PIPKIβwt and HA-PIPKIβ 456 immunoprecipitated from HEK-293 cells before or after 
stimulation with the chemoattractant CXCL12. Both HA-PIPKIβwt and HA-PIPKIβ 456 showed 
basal kinase activity in unstimulated cells, which increased after chemoattractant stimulation (Fig. 5 
E). Generation of PI(4,5)P2 was not observed
 in immunoprecipitates of the kinase-dead HA-
PIPKIβK138A or HA-PIPKIβ 456K138A mutants, indicating kinase assay specificity (Fig. 5 E). 
These results thus suggest that chemoattractants stimulate PIPKIβ lipid kinase activity. 
Chemoattractant stimulation nonetheless did not increase total PI(4,5)P2 levels
 in PIPKIβwt- or HA-
PIPKIβ 456-expressing cells (Fig. S2 A, available at 
http://www.jcb.org/cgi/content/full/jcb.200705044/DC1); furthermore, total PI(4,5)P2 levels were 
not increased by PIPKIβwt or HA-PIPKIβ 456 overexpression, compared with mock-transfected 
cells. 
We thus analyzed local changes in PI(4,5)P2 during PIPKIβwt-
 and PIPKIβ 456-expressing dHL60 
cell chemotaxis using the pleckstrin homology (PH) domain of PLC  tagged with GFP (GFP-PH-
PLC ). Overexpression of GFP-PH-PLC  drastically inhibited chemotaxis in these cells (unpublished 
data), however, compromising data interpretation. A considerable proportion of GFP-PH-PLC –
expressing dHL60 still polarized after homogeneous stimulation with fMLP. In polarized mock and 
RFP-PIPKIβwt-expressing cells, GFP-PH-PLC  accumulated at the leading edge and the uropod 
(Fig. S2, B and C). In contrast, PI(4,5)P2 co-redistributed with RFP-PIPKIβ 456
 in random patches 
in the periphery of PIPKIβ 456-expressing cells (Fig. S2 D).  
Because chemoattractants stimulate PIPKIβ 456-mediated PI(4,5)P2
 production, PIPKIβ 456 
might prevent dHL60 cell polarization by "delocalizing" the source of PI(4,5)P2; elevated PI(4,5)P2
 
levels might in turn generate PIP3 at inappropriate cell sites.
 A kinase-dead version of PIPKIβ 456 
(PIPKIβ 456K138A) nonetheless inhibited fMLP-induced dHL60 cell polarization as efficiently as 
the kinase-active PIPKIβ 456 (Fig. 5 F); moreover, fMLP-induced AKT phosphorylation, an 
indirect readout of PIP3 levels, was comparable in cells expressing the kinase-active
 or kinase-dead 
mutants (Fig. S2 E). These results indicate that the dominant-negative effects of PIPKIβ 456 on cell 
polarity are independent of its lipid kinase activity. PIPKIβwt overexpression also restored fMLP-
induced cell polarity in PIPKIβ 456-expressing dHL60 cells (Fig. 5 G), suggesting that through a 
region distinct from the C terminus, PIPKIβ binds to other protein(s) with an important role in cell 
polarity.  
Overexpression of the PIPKIβ 456 mutant inhibits RhoA activation at the uropod 
We found that PIPKIβ 456 overexpression resulted in homogeneous, largely cytosolic distribution 
of RhoA after uniform fMLP stimulation, which contrasted with the uropod RhoA distribution in 
PIPKIβwt-expressing cells (Fig. 6 A). Stimulation of untransfected dHL60 or HEK-293 cells with 
fMLP or the chemokine CXCL12, respectively, induced a transient increase in RhoA activity after 
30–60 s (Fig. S3A, available at http://www.jcb.org/cgi/content/full/jcb.200705044/DC1). This 
pattern was not altered in mock- or PIPKIβ-expressing cells, but PIPKIβ 456 overexpression 
reduced chemoattractant-induced RhoA activation (Fig. 6 B). siRNA-induced reduction of 
endogenous PIPKIβ also diminished fMLP-induced RhoA activation in dHL60 cells (Fig. 6 C), 
suggesting PIPKIβ involvement in RhoA activation.  
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We next analyzed the phosphorylation of MLC (pS19-MLC), a target of the RhoA-ROCK pathway, 
in fMLP-stimulated cells. We found an acute reduction in pS19-MLC in PIPKIβ 456-expressing 
cells compared with PIPKIβwt-expressing cells (Fig. 6 D); pS19-MLC levels were recovered in 
PIPKIβ 456- expressing cells by coexpressing PIPKIβwt (Fig. 6 D). We detected a slight, 
nonsignificant reduction in phospho-MLC staining in cells expressing the kinase-dead PIPKIβK138A 
mutant (Fig. 6 D). As an antibody specificity control, fMLP-induced pS19-MLC levels were reduced 
after cell treatment with the ROCK inhibitor Y27632 (Fig. S3 B). 
The PIPKIβ C terminus interacts with EBP50, ERM proteins, and RhoGDI 
We searched for proteins that interact with the 83aa-tail, using affinity purification of a dHL60 
detergent extract on 83aa-tail GST fusion protein (Fig. 7 A). Four bands were selectively retained by 
the PIPKIβ 83aa-tail, which were identified by matrix-assisted laser desorption/ionization-time-of-
flight (MALDI-TOF) mass spectrometry of tryptic digests as spectrin , a 110-kD protein with 
spectrin β homology, moesin, and EBP50 (also termed sodium-proton exchanger regulatory factor 1), 
an adaptor for ERM proteins (Reczek et al., 1997). In addition, the 83aa-tail retained an unidentified 
67-kD protein. Moesin represents more than 90% of the ERM proteins expressed in dHL60 cells 
(Ivetic and Ridley, 2004; and unpublished data); it is thus feasible that rescue of moesin in the pull-
down assay indicates the ability of the 83aa-tail to interact with ERM proteins.  
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Figure 6. PIPKIβ controls signaling at the uropod. (A) PIPKIβwt- and 
PIPKIβ 456-expressing dHL60 cells were exposed to uniform fMLP 
attractant, and stained with anti-RhoA antibody (red). Nomarski, red, and 
green channels are shown. Cells represent at least 15 cells (n = 3). (B) 
Mock-, PIPKIβwt- and PIPKIβ 456-transfected HEK-293 cells were 
stimulated in suspension with CXCL12. At the times indicated, RhoA-GTP 
levels were determined with a luminometry-based assay. Values were 
normalized to those obtained in unstimulated cells and expressed as x-
fold of induction. (C) Control or PIPKIβ-specific siRNA-transfected dHL60 
cells were stimulated with fMLP and RhoA-GTP levels determined. 
Values were normalized to those obtained in unstimulated control siRNA-
transfected cells. For B and C, data are mean ± SEM of values obtained 
in three independent experiments. (D) GFP-PIPKIβwt-, GFP-PIPKIβK138A-
, and GFP-PIPKIβ 456-expressing dHL60 cells, and cells coexpressing 
RFP-PIPKIβwt and GFP-PIPKIβ 456 were stimulated as in A, and MLC 
phosphorylation analyzed by staining with a pS19-MLC–specific antibody 
(red or blue, as indicated). (E) Quantification of the pS19-MLC staining 
area of cells in D. Data are mean ± SEM of 20–35 cells recorded in three 
independent experiments. (*, P < 0.05, two-tailed Dunnett's test). Bar, 10 
µm. 
 
View larger version (37K): 
Figure 7. The PIPKIβ C terminus interacts with moesin and 
EBP50. (A) Pull-down assays were performed using the 83aa-
tail fused to GST, or GST alone. Proteins were resolved in 
SDS-PAGE; proteins bound differentially to GST-83aa-tail and 
to GST were identified by MALDI-TOF mass spectrometry. 
Results shown are representative of two independent 
experiments. (B and C) Localization of endogenous phospho-
ERM proteins (p-ERM) and EBP50 in GFP-PIPKIβwt- (B) and 
GFP-PIPKIβ 456-expressing dHL60 cells (C) by 
immunofluorescence. Cells are representative of 30 cells 
recorded in two independent experiments; bar, 10 µm. 
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Immunofluorescence analysis of the proteins that bind the 83aa-tail indicated homogeneous spectrin 
 juxtamembrane staining in fMLP-stimulated dHL60 cells (unpublished data); in contrast, phospho-
ERM and EBP50 polarized to the uropod of fMLP-stimulated PIPKIβwt-expressing cells (Fig. 7 B). 
Notably, PIPKIβ 456 overexpression prevented polarization of these uropod markers (Fig. 7 C). 
We tested 83aa-tail-GST binding to biotin-labeled, in vitro–translated moesin or EBP50. 
Recombinant moesin did not bind to 83aa-tail-GST (unpublished data), but in vitro–translated 
EBP50 bound very efficiently to the 83aa-tail-GST (Fig. 8 A); more important, the in vitro–
translated moesin FERM (band 4.1 protein-ezrin-radixin-moesin) domain bound to the 83aa-tail-
GST protein only in the presence of EBP50 (Fig. 8 A). These results suggested that EBP50 might 
regulate the interaction between ERM proteins and the PIPKIβ C terminus in a chemoattractant-
dependent manner.  
We analyzed the interaction of EBP50 and ERM proteins in PIPKIβwt- and PIPKIβ 456-expressing 
cells. ERM proteins coprecipitated with PIPKIβwt after chemoattractant stimulation in 
immunoprecipitation assays; as predicted, this association was not observed for PIPKIβ 456 (Fig. 8 
B). Moreover, chemoattractant stimulation induced time-dependent association between ERM and 
EBP50, but only in cells overexpressing PIPKIβwt (Fig. 8 C); EBP50 appeared as a doublet in these 
immunoprecipitates, probably as a consequence of phosphorylation. Together, these results suggest 
that the PIPKIβ 83aa-tail regulates formation of a complex between ERM proteins and EBP50 after 
chemoattractant stimulation.  
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Figure 8. The PIPKIβ C terminus regulates ERM protein 
interaction with RhoGDI. (A) Equal amounts of GST-83aa-tail 
and GST proteins were incubated with 12 µl of biotinylated 
EBP50 and/or moesin FERM; bound proteins were analyzed by 
blotting with peroxidase-labeled streptavidin to detect 
biotinylated proteins (top panel) and Ponceau red for the GST 
and GST-83aa-tail (bottom panel). Relative migration of in vitro–
translated EBP50 and moesin FERM domain (1 µl/lane) in the 
absence of GST proteins is shown (first and last lanes). (B) HA-
tagged PIPKIβwt- and PIPKIβ 456-expressing HEK-293 cells 
were stimulated in suspension with CXCL12 for the times 
indicated (in seconds). ERM proteins were immunoprecipitated 
and bound proteins analyzed sequentially with anti-HA and anti-
ERM protein antibodies. Arrows indicate the relative migration 
of HA-PIPKIβwt- and HA-PIPKIβ 456 proteins. E indicates cell 
extract. (C) The lysates in B were immunoprecipitated with anti-
ERM protein antibody and blotted with anti-EBP50 and -ERM 
antibodies. (D) HEK-293 cells were cotransfected with myc-
tagged RhoGDI and either HA-tagged PIPKIβwt or -PIPKIβ
456, and stimulated in suspension with CXCL12. Cell lysates 
were immunoprecipitated with anti-HA antibodies and bound 
proteins blotted for RhoGDI (myc tag) and PIPKIβ (HA tag). (E) 
Cell lysates from CXCL12-stimulated HEK-293 cells 
coexpressing myc-RhoGDI and HA-PIPKIβwt- or HA-PIPKIβ
456 were immunoprecipitated with anti-myc antibodies, then 
blotted sequentially with anti-HA, -ERM proteins, and -myc 
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ERM proteins act upstream of Rho GTPases by interacting with RhoGDI, enabling RhoA activation 
(Takahashi et al., 1997). Based on the association between ERM proteins and the 83aa-tail, we found 
that chemoattractants induced coprecipitation of RhoGDI with overexpressed PIPKIβwt, whereas 
only a small amount PIPKIβ 456 could be detected in these immunoprecipitates (Fig. 8, D and E). 
Moreover, we did not detect ERM-RhoGDI complexes in immunoprecipitates of PIPKIβ 456-
expressing cells (Fig. 8 E). 
 
  
Here we identified uropodal PIPKIβ localization as an important step in 
the organization of signaling involved in neutrophil polarity and 
chemotaxis. We found that (1) PIPKIβ polarized to the uropod after 
chemoattractant stimulation; (2) RNAi-induced knockdown of PIPKIβ 
impaired neutrophil polarity and chemotaxis as well as RhoA activation, 
indicating the relevance of the endogenous enzyme in these processes; (3) uropod PIPKIβ 
localization required the C-terminal 83aa-tail; (4) catalytically active or inactive PIPKIβ mutants 
lacking the C terminus prevented spatial and functional cell asymmetry and gradient sensing; and (5) 
the C-terminal 83aa-tail interacted with different adapters including, but not limited to, EBP50, 
moesin, and RhoGDI.  
siRNA attenuation of PIPKIβ levels inhibited dHL60 cell polarity, impaired persistence during 
chemotaxis, and reduced chemoattractant-induced RhoA activation, although the effects were less 
dramatic than those observed for the PIPKIβ 456 mutant. One explanation for these mild effects is 
that other PIPKI isozymes might compensate for the PIPKIβ deficiency. Results from PIPKIβ-null 
mice support this idea; although PIPKIβ has an exclusive role in modulating the actin cytoskeleton in 
mast cells, no major phenotypic defects were reported in these mice (Sasaki et al., 2005). The long 
PIPKI 661 isozyme is a candidate for PIPKIβ compensation, although a recent report suggests that 
this isoform is not required for G protein–coupled receptor-stimulated chemotaxis (Sun et al., 2007). 
The interplay between PIPKIβ and PIPKI 661 during leukocyte chemotaxis and the identity of their 
targets require further study.  
Activation of ERM proteins requires two signals, PI(4,5)P2 binding,
 and threonine phosphorylation 
within the actin-binding domain (Ivetic and Ridley, 2004). PI(4,5)P2 is thought to recruit ERM
 
proteins to the membrane by unfolding inactive monomers, whereas phosphorylation is believed to 
stabilize the active open conformation (Fievet et al., 2004). The FERM domain of active ERM 
proteins can then interact with RhoGDI, triggering RhoA activation (Takahashi et al., 1997); this in 
turn can induce further ERM activation through ROCK- or PIPKI-dependent mechanisms (Chong et 
al., 1994; Matsui et al., 1999; Santarius et al., 2006). In vitro kinase assays indicate that 
chemoattractants stimulate PIPKIβ-mediated PI(4,5)P2 production.
 Local PIPKIβ-mediated PI(4,5)
P2 production might trigger
 ERM activation locally, initiating or boosting this feedback loop.  
antibodies. Arrows indicate the relative migration of HA-
PIPKIβwt and HA-PIPKIβ 456. The blots are representative of 
three independent experiments. 
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The phenotype observed in cells expressing the kinase-dead mutant is puzzling, however. 
Chemotaxing PIPKIβK138A-expressing cells showed defects in tail retraction (Video 4) and a severe 
reduction in speed. Uropod detachment requires RhoA/ROCK-induced myosin II contraction (Alblas 
et al., 2001; Worthylake et al., 2001), suggesting that PI(4,5)P2 production participates in PIPKIβ-
mediated RhoA activation. Nonetheless, PIPKIβK138A expression only minimally affected pS19-
MLC phosphorylation, which is controlled by the RhoA/ROCK pathway. This result suggests that 
local PIPKIβ-induced PI(4,5)P2 production is dispensable for RhoA activation; alternatively,
 PIPKIβ 
might regulate dHL60 cell chemotaxis via another mechanism(s) besides, or in addition to RhoA 
activation.  
The most severe phenotype was observed in cells expressing the PIPKIβ 456 mutant, which lacks 
the uropod targeting sequence in the 83aa-tail. PIPKIβ 456-expressing cells cannot establish a stable 
front–rear asymmetry axis, leading to membrane ruffling or AKT-PH recruitment to cell edges up 
and down the gradient. PIPKIβ 456 expression does not abrogate signals associated to the leading 
edge, but this mutant impaired chemoattractant-induced RhoA activation and pS19-MLC 
phosphorylation in the uropod. Notably, ERM proteins did not coprecipitate detectably with RhoGDI 
in PIPKIβ 456-overexpressing cells (Fig. 8). Based on these results, PIPKIβ polarization at the 
uropod might be a mechanism for signal localization at the cell posterior.  
It is intriguing that these PIPKIβ 456 effects occurred in cells expressing endogenous PIPKIβ, 
which suggests that PIPKIβ 456 acts as a dominant-negative mutant. Chemoattractants stimulated 
PIPKIβ 456-mediated PI(4,5)P2 production; it
 is nonetheless unlikely that the PIPKIβ 456 
phenotype is a consequence of delocalized PI(4,5)P2 synthesis because the
 kinase-dead PIPKIβ
456K138A mutant impedes cell polarity. PIPKIβ 456 cannot engage the EBP50-ERM-RhoGDI 
complex (Fig. 8). The dominant-negative phenotype of the PIPKIβ 456 mutant could be explained 
by assuming that the PIPKIβ N terminus or the common kinase domain might interact with other 
effectors or adaptors critical for neutrophil polarization. PIPKIβ 456 would thus sequester these 
effectors/adaptors, preventing their interaction with endogenous PIPKIβ (which is expressed at much 
lower levels than the mutant). In support of this idea, coexpression of PIPKIβwt restored fMLP-
induced polarization of PIPKIβ 456-expressing dHL60 cells (Fig. 5 G). Identification of these 
additional PIPKIβ-interacting proteins will require future experiments.  
In conclusion, we have determined that PIPKIβ is a new element in the regulation of neutrophil 
polarity and chemotaxis. PIPKIβ polarizes at the cell posterior through its C-terminal domain, which 
interacts with other uropod proteins such as EBP50 and ERM. Given that EBP50 is a PDZ 
(postsynaptic density protein, disc-large, zonulin-1)-containing protein, it is possible that EBP50 
links PIPKIβ to a network of PDZ proteins known to shape the uropod in other leukocytes (Ludford-
Menting et al., 2005). PIPKIβ might thus participate in several signaling networks involved in 
leukocyte uropod identity.  
 
  
Antibodies and reagents 
Anti–human PIPKI , β, and , anti-myc clone 9E10, and anti-RhoA 
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antibodies were obtained from Santa Cruz Biotechnology, Inc.; anti-
phospho-ERM, -ERM, -pS19-MLC, -phospho AKT, and -spectrin II 
were from Cell Signaling Technology; anti-Rac and anti-AKT from 
Millipore; anti-EBP50 from Affinity BioReagents; anti-HA from 
Covance; anti-moesin from BD Biosciences; anti-ezrin from Invitrogen; 
peroxidase-labeled anti–mouse and anti–rabbit IgG from Dako; and biotinylated anti–rabbit IgG and 
cy2- and cy3-conjugated secondary antibodies from Jackson ImmunoResearch Laboratories. Anti-
GST antibodies, Tri-reagent, PTX, Ficoll-Hypaque, Ponceau S red, fibronectin, DMSO, and fMLP 
were from Sigma-Aldrich; human CXCL12 was from PeproTech. The TNT transcription–translation 
system, Transcend Non-Radioactive Translation Detection Systems, trypsin, and peroxidase-labeled 
streptavidin were from Promega.  
Cloning and generation of PIPKIβ mutants 
cDNAs encoding mouse PIPKI , β, and , and the kinase-dead PIPKIβK138A mutant were a gift of 
H. Isihara (University of Geneva, Geneva, Switzerland) and were subcloned in pEGFP-C1 (Clontech 
Laboratories, Inc.), pRFP-C3 (a gift of L. Rajendran, Max-Planck-Institute for Molecular Cell 
Biology and Genetics, Dresden, Germany), or pcDNA3.1-HA (a gift of T. Fischer; Centro Nacional 
de Biotecnología/CSIC, Madrid, Spain) to generate the GFP-, RFP-, and HA-chimeras, respectively. 
The deletion and swapping mutants were generated using PCR and pfu Turbo DNA polymerase 
(Stratagene) and cloned in pEGFP-C1, pRFP-C3, and pcDNA3.1-HA (from T. Fischer; Centro 
Nacional de Biotecnología, Madrid, Spain) to obtain the corresponding tag-fusion proteins. The C-
terminal fragment of PIPKI  (83aa-tail) was subcloned in pEGFP-C1 to generate the GFP chimera 
and in pGEX-4-T1 (GE Healthcare) for expression as a GST fusion protein in Escherichia coli. The 
ezrin FERM domain, a gift from M. Arpin (Institut Curie, Paris, France), was cloned in pcDNA3.1-
HA and in pGEX-4-T1. The catalytically inactive G 12
(Q209L/D277N) and G 13
(Q226L/D294N) 
mutants (UMR cDNA Resource Center) were cloned in the pRV-IRES-GFP bicistronic plasmid 
(Genetrix). Dominant-negative G 12 and G 13
 mutants were generated by cloning the C-terminal 
fragments of these G proteins in pCDNA3.1-HA. The Rac PBD was subcloned in pEGFP-C3; the 
GFP-PLC -PH domain was a gift of C. Schneider and P. Caroni (Friedrich Miescher Institute, Basel, 
Switzerland); myc-tagged RhoGDI was a gift of B. Olofsson (Centre National de la Recherche 
Scientifique, Gif-sur-Yvette, France). The EBP50 and moesin gene cDNA (Open Biosystems) were 
cloned in pCDNA3.1HA. The moesin FERM domain was amplified by PCR and cloned in 
pcDNA3.1-HA and in pGEX-4-T1. The GFP-AKT-PH domain and GFP-RhoN19 have been 
described (Gómez-Moutón et al., 2004).  
Cell culture and transfections 
HL60 cells were maintained in RPMI 1640 with 10% FCS and differentiated with 1.3% DMSO for 7 
d. Differentiated cells were transfected with the indicated plasmids by electroporation (2 x 107 cells, 
320 mV, 1,000 µF) in an electroporator (Bio-Rad Laboratories), or using the T Cell Nucleofector kit 
(Amaxa Biosystems); protein expression was analyzed 6–12 h after transfection by FACS (Beckman 
Coulter), and live cells isolated on Ficoll-Hypaque gradients. Transfection efficiency was typically 
15–20%. Jurkat cells were cultured in RPMI 1640 with 10% FCS and transfected as described 
(Gómez-Moutón et al., 2004). HEK-293 cells were maintained in DME with 10% FCS. Cells were 
transiently transfected with the indicated plasmids using the standard calcium phosphate method, and 
protein expression analyzed 48 h later (transfection efficiency was 70–80%).  
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siRNA experiments 
dHL60 cells were transfected with two human PIPKIβ-specific or nonspecific siRNA duplexes (50 
nM; Dharmacon) using Jet-siENDO (Polyplus Transfection). The sequences of the PIPKIβ-specific 
siRNA duplexes were: 5'-GGCAGACAGAUUUCUUAAGUUU-3' and 5'-
UAAGACAUACGUCCAUUAUU-3'. In all experiments, a Cy3-labeled nonspecific duplex control 
(Dharmacon) was transfected with control or specific duplexes to determine transfection efficiency 
(usually 98–100% by FACS). PIPKIβ silencing was analyzed 24 and 48 h after transfection by 
quantitative RT-PCR using Taqman probes (Applied Biosystems) specific for the human PIPK , β, 
and  genes. Ct values provided by the software of the apparatus were normalized using 18S RNA, 
and the relative mRNA levels calculated using the formula 2 – ( Ct sample – Ct control). GAPDH 
amplification was performed in each experiment as an internal control. PIPKIβ silencing was 
analyzed 48 h after transfection by sequential immunoblotting with anti-PIPKIβ and anti-actin 
(loading control) antibodies.  
Time-lapse confocal videomicroscopy and chemotaxis assays 
Real-time cell chemotaxis was studied by time-lapse confocal microscopy as described (Gómez-
Moutón et al., 2004). Starved cells were plated (1 h, 37°C) on fibronectin-coated chamber coverslips 
(Nunc) and stimulated with fMLP (100 nM) applied with a micropipette at 37°C. Fluorescence and 
phase-contrast images were recorded in a confocal microscope (TCS-NT; Leica) with a 63x NA1.4 
oil plan-Apo objective with an electronic zoom of 2 at established time intervals. Brightness and/or 
contrast were adjusted, and videos were processed with ImageJ software (National Institutes of 
Health, Bethesda, MD). Motility parameters and cell tracks from these videos were obtained using 
the MetaMorph Imaging System (Meta Imaging Software). The directional index was calculated as 
the net distance moved toward the chemoattractant source divided by the cumulative length of the 
migration path. Cell velocity was defined as the net distance divided by the time used to cover it. 
Plots showing trajectories of different cells were composed in Adobe Photoshop.  
For transwell assays, 1–2 x 105 PIPKIβ-expressing, Y-27632-pretreated (10 µM, 1 h; Calbiochem), 
or siRNA-transfected dHL60 cells were seeded in the upper chamber in serum-free medium; lower 
chambers were filled with serum-free medium alone or containing fMLP (100 nM). Transmigrated 
cells were quantified by FACS after incubation (2.5 h, 37°C). The percentage of migrating cells was 
calculated as the quotient of the number of migrating fluorescent cells in the lower chamber and the 
fluorescent cells in the initial input.  
Immunofluorescence and cell polarity assays 
Serum-starved Jurkat- and dHL60-transfected cells were plated on fibronectin-coated slides and, 
after incubation (1 h, 37°C), were stimulated with CXCL12 (100 nM, 10 min, 37°C) or fMLP (100 
nM, 3 min, 37°C). After washing, plates were fixed with 3.7% paraformaldehyde (10 min, 20°C) in 
PBS, permeabilized with 0.1% Triton X-100 (5 min, 20°C), and incubated (1 h, 4°C) with the 
indicated primary antibody, followed by the appropriate Cy2- or Cy3-conjugated secondary 
antibody. Samples were mounted in Vectashield medium (Vector Laboratories) and images recorded 
in a confocal microscope (Fluoview 10; Olympus) with a 60x 1.4NA oil plan-Apo objective, using 
FV10-ASW 1.6 software (Olympus). Brightness and/or contrast were adjusted with ImageJ software. 
In some experiments, starved cells were treated with PTX (0.5 mg/ml, 16 h, 37°C) or Y-27632 (10 
µM, 1 h, 37°C), and plated on Fn-coated slides. PTX and Y-27632 were maintained throughout the 
assay.  
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Cell polarization in siRNA-transfected cells was determined by F-actin staining with phalloidin-
rhodamine (Invitrogen) and anti-phospho-ERM. Cells showing both accumulation of actin at the 
leading edge and phospho-ERM at the uropod were scored as polarized. Eight random fields were 
recorded per condition and at least 200 cells were counted per sample in three independent 
experiments.  
pSer19-MLC levels were quantified as described (Jiménez-Baranda et al., 2007). In brief, dHL-60 
cells stained with anti-pSer19-MLC antibody and were serially scanned in horizontal sections 0.6 µm
apart; section 4 was used for quantification. The same black and white threshold was then applied to 
all images collected (upper threshold level 76, lower threshold level 30). The image was scaled (512 
pixels = 152.4 µm; pixel/aspect ratio = 1) and particle measurement automatically performed using 
ImageJ software.  
Lipid kinase assays 
Serum-starved mock-, HA-PIPKIβ-, HA-PIPKIβK138A-, HA-PIPKIβ 456-, and HA-PIPKIβ
456K138A-expressing HEK-293 cells were stimulated in suspension with CXCL12 (100 nM, 1 min,
37°C) for the times indicated. HA-tagged enzymes were immunoprecipitated from cell extracts and 
lipid kinase activity was determined as described (Jones et al., 2000). The kinase reaction mix (50 µl) 
contained 200 µM PI4P (Echelon Biosciences), 20 µM ATP, 10 mM MgCl2, and 10 µCi [
32]ATP 
(GE Healthcare). Radioactive spots with an Rf value corresponding to PI(4,5)P2
 were identified by 
autoradiography after TLC.  
The amount of PI(4,5)P2 was measured in cell extracts from mock-,
 PIPKIβ-, and PIPKIβ 456-
expressing HEK-293 cells before and after CXCL12 stimulation (100 nM, 2 min, 37°C) using the PI
(4,5)P2 Mass Strip kit (Echelon Biosciences) according
 to the supplier's protocol.  
Rho activation assay 
RhoA activity was determined using the luminescence-based G-LISA RhoA Activation Assay 
Biochem kit (Cytoskeleton, Inc.). PIPKIβ-specific and mismatched siRNA transfected-dHL60 cells 
or mock-, PIPKIβ-, or PIPKIβ 456-expressing HEK-293 cells were starved and maintained in 
suspension. Cells were stimulated with fMLP (100 nM) or CXCL12 (100 nM) for the indicated times 
and assayed according to the supplier's protocol.  
In vitro and in vivo analysis of PIPKIβ interactions 
For pull-down assays, GST-83aa-tail or GST proteins were produced in E. coli and purified using 
glutathione Sepharose 4B (GE Healthcare). dHL60 cells (2 x 108) were stimulated with fMLP (100 
nM, 5 min, 37°C) and extracts were prepared immediately with RIPA buffer (50 mM Tris-HCl, pH 
7.5, 0.15 M NaCl, 0.1% SDS, 0.5% deoxycholate, and 1% NP-40). After preclearing with GST, cell 
extracts were incubated (overnight, 4°C) with GST-83aa-tail or GST bound to glutathione Sepharose. 
Beads were washed and retained proteins eluted with SDS sample buffer; after boiling for 5 min, 
proteins were resolved by SDS-PAGE and stained with Coomassie blue. Protein identification was 
performed by the Proteomics Core Facility (see below).  
Pull-down assays were also performed with in vitro–transcribed and –translated EBP50, moesin, and 
HA-moesin FERM domain using the TNT system (T7 promoter), incorporating biotinylated lysine 
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residues in the nascent proteins. Interaction of the GST-83aa-tail or GST with the prey proteins was 
performed in binding buffer (PBS, 1% BSA, 0.02% Triton X-100) for 1 h at 4°C. After washing with 
PBS containing 0.05% Triton X-100, the proteins were eluted in SDS sample buffer and analyzed by 
immunoblot using peroxidase-labeled streptavidin. Before immunoblotting, nitrocellulose 
membranes were stained with Ponceau S red to visualize GST proteins.  
For immunoprecipitation, serum-starved HEK-293 cells transfected with PIPKIβ or PIPKIβ 456 
were stimulated in suspension with 100 nM CXCL12 (37°C) for the indicated times, placed on ice, 
washed with ice-cold PBS, and lysed with RIPA buffer. Cell extracts (300 µg) were 
immunoprecipitated (2 h, 4°C) with anti-HA, -ERM, -myc, or –mouse IgG antibody, followed by 
incubation (1 h, 4°C) with Gamma-Bind Plus Sepharose (GE Healthcare). Immunoprecipitates were 
resolved in SDS-PAGE and analyzed by immunoblot with anti-HA, -ERM, and -myc antibodies.  
Proteomic techniques 
Proteins from stained one-dimensional polyacrylamide gels were excised and processed in 96-well 
plates in a Proteineer DP (Bruker Daltonics). For protein digestion, gel plugs were washed with 50 
mM NH4HCO3 and treated with acetonitrile before reduction
 (10 mM DTT in 25 mM NH4HCO3) 
and alkylation (55 mM iodoacetamide in 50 mM NH4HCO3). Proteins were trypsin-digested (15 
ng/µl in 25 mM NH4HCO3, 4 h, 37°C). Peptides were eluted from
 gel pieces with 0.5% 
trifluoroacetic acid (TFA) in water (30 min, 25°C). Peptides were analyzed by MALDI-TOF MS; 0.5
µl matrix solution (5 mg/ml 2,5-dihydrobenzoic acid in 33% [vol/vol] aqueous acetonitrile and 0.1% 
[vol/vol] TFA) was added to a 600-µm AnchorChip MALDI target (Bruker Daltonics) and dried at 
room temperature. A 0.5 µl aliquot of each peptide mixture was deposited onto matrix spots and 
dried.  
MALDI peptide mass fingerprinting was acquired on a Bruker Reflex IV MALDI-TOF mass 
spectrometer with SCOUT source in positive ion reflector mode (ion acceleration voltage 23 kV). 
Spectra were acquired with FlexControl 2.4 and processed with Flex Analysis 2.4. Equipment was 
externally calibrated using protonated mass signals from a peptide mixture (1,000–3,500 m/z range). 
For peak list generation, each spectrum was internally calibrated with two known trypsin 
autoproteolysis peptides; typical mass measurement accuracy was ±30 ppm (800–3,000 m/z range). 
Data analysis parameters were a signal-to-noise threshold of 20 and resolution >4,000.  
For protein identification, the tryptic peptide masses were batch processed and searched against the 
nonredundant National Center for Biotechnology Information (NCBI) database using Mascot 2.1 
(Matrix Science) through the Bruker Biotools 2.0 interface. Search parameters were 
carbamidomethyl cysteine (fixed modification), oxidized methionines (variable modification), 
peptide mass tolerance of 80 ppm, with one missed cleavage site allowed. For all proteins, the 
probability-based Mowse scores were greater than the minimum score fixed as significant (P < 0.02).
Statistical analysis 
Data are expressed as mean ± SEM. Dunnett two-tailed or Student's two-tailed t tests were used to 
compare differences between groups in various experiments.  
Online supplemental material 
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Figure S1 shows the analysis of HA-tagged PIPKIβ localization in dHL60 neutrophil-like cells and 
Jurkat T cells, as well as additional images for endogenous PIPKI isoforms and the kinase-dead 
PIPKIβK138A mutant in fMLP-stimulated cells. Figure S2 shows the analysis of PI(4,5)P2 and PIP3 
levels in PIPKIβ-expressing cells. Figure S3 shows the analysis of RhoA activity in dHL60 and 
HEK-293 cells stimulated with fMLP and CXCL12, respectively, as well as analysis of antibody 
specificity for pS19-MLC. Video 1 shows PIPKIβ polarization to the uropod during dHL60 cell 
chemotaxis. Video 2 shows that PIPKI  does not polarize during dHL60 cell chemotaxis. Video 3 
shows the homogeneous distribution of PIPKI 635 during dHL60 cell chemotaxis. Video 4 shows 
distribution of the kinase-dead PIPKIβK138A mutant during dHL60 cell chemotaxis. Video 5 shows 
the cellular localization of the C terminus–deleted PIPKI 1–502 mutant in chemotaxing dHL60 cells. 
Video 6 shows the dynamics of the GFP-tagged chimera formed by the C terminus–deleted PIPKI 1–
502 mutant and the PIPKIβ C terminus (PIPKI 1–502β455–539), during chemotaxis toward fMLP. 
Video 7 shows time-lapse confocal images of dHL60 cells coexpressing AKT-PH-GFP and RFP-
PIPKIβwt migrating toward fMLP. Video 8 shows that overexpression of the PIPKIβ 456 mutant 
impedes polarization of PI3K signaling in directionally stimulated dHL60 cells. Video 9 shows that 
PIPKIβwt-expressing dHL60 cells persistently polarize Rac signaling during chemotaxis. Video 10 
shows that PIPKIβ 456 overexpression inhibits polarization of Rac signaling in directionally 
stimulated dHL60 cells. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200705044/DC1.  
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